Panel Discussion: Defining the Therapeutic Windows of Drugs to Ensure Patient Safety Whilst Maintaining Drug Efficacy
Time: 9:50 am
day: Day One
Details:
- Balancing the therapeutic index versus safety in targeting complement
- Discussing this in the context of disease versus healthy complement inhibition
- Reviewing the therapeutic window when you target classical, lectin or alternative pathways
- Discussing pharmacokinetics of targeting complement
- Specifying inclusion/exclusion criteria put in place specifically due to safety considerations e.g. avoiding comorbidities or infections
